URB447 Is Neuroprotective in Both Male and Female Rats after Neonatal Hypoxia–Ischemia and Enhances Neurogenesis in Females
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25031607 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Gorane Beldarrain und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology and Histology, School of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain. Hauptthemen laut MEDLINE: Hypoxia-Ischemia, Brain, Neuroprotective Agents, Cannabinoids, Brain Injuries. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Asuntos Económicos y Transformación Digital, Predocotral grant: Programa Investigo by the European Union-Next Generation EU, Predoctoral grant by UPV/EHU.
Abstract (Originalsprache)
The need for new and effective treatments for neonates suffering from hypoxia–ischemia is urgent, as the only implemented therapy in clinics is therapeutic hypothermia, only effective in 50% of cases. Cannabinoids may modulate neuronal development and brain plasticity, but further investigation is needed to better describe their implication as a neurorestorative therapy after neonatal HI. The cannabinoid URB447, a CB1 antagonist/CB2 agonist, has previously been shown to reduce brain injury after HI, but it is not clear whether sex may affect its neuroprotective and/or neurorestorative effect. Here, URB447 strongly reduced brain infarct, improved neuropathological score, and augmented proliferative capacity and neurogenic response in the damaged hemisphere. When analyzing these effects by sex, URB447 ameliorated brain damage in both males and females, and enhanced cell proliferation and the number of neuroblasts only in females, thus suggesting a neuroprotective effect in males and a double neuroprotective/neurorestorative effect in females.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology and Histology, School of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.
- Department of Surgery and Radiology and Physical Medicine, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.
ORCID-Profile: Gorane Beldarrain, Marc Chillida, Borja Herrero de la Parte
Förderung
- Ministerio de Asuntos Económicos y Transformación Digital
- Predocotral grant: Programa Investigo by the European Union-Next Generation EU
- Predoctoral grant by UPV/EHU
- MCIN/AEI/10.13039/501100011033
- Programa Investigo by the European Union-Next Generation EU
- UPV/EHU
Zitieren
APA
Beldarrain, G., Chillida, M., Hilario, E., Herrero de la Parte, B., Álvarez, A., & Alonso-Alconada, D. (2024). URB447 Is Neuroprotective in Both Male and Female Rats after Neonatal Hypoxia–Ischemia and Enhances Neurogenesis in Females. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25031607
Vancouver
Beldarrain G, Chillida M, Hilario E, Herrero de la Parte B, Álvarez A, Alonso-Alconada D. URB447 Is Neuroprotective in Both Male and Female Rats after Neonatal Hypoxia–Ischemia and Enhances Neurogenesis in Females. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25031607
BibTeX
@article{Beldarrain2024,
author = {Beldarrain, Gorane and Chillida, Marc and Hilario, Enrique and Herrero de la Parte, Borja and Álvarez, Antonia and Alonso-Alconada, Daniel},
title = {URB447 Is Neuroprotective in Both Male and Female Rats after Neonatal Hypoxia–Ischemia and Enhances Neurogenesis in Females},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25031607}
}
EUVIMED